specialti pharma top-read note may
remain read myl/teva drive call volum
includ link notes/report publish month may proxi
see greatest investor interest top note rank order read
larger cap coverag continu drive focu rel publish research includ agn
high readership month captur sharehold vote result receiv
lot investor focu overal stock made top note investor interest remain
high ii weak came front sector sell-off sinc three stock
specif note top iii gener interest gener high sector sell-
steadi request transcript link expert price fix alleg call
notes/report may top rank order read activ link
remaind page
investor frustrat justifi chang need lower price target may
agn struggl see realist upsid case lower target may
agn break-up still bull case street margin also still high drill may
agn closer look bull/bear debat push strateg action still biggest focu may
agn stock weak persist three topic focu updat thursday may
industri gener pharma price fix expert call takeaway thought possibl cost/tim read
teva may
closer look bull/bear debat call chang continu expect low may
agn proxi vote result fall short still send messag manag need address may
pose top question manag ahead call favor set-up may
main theme manag dinner firesid chat healthcar confer
industri specialti pharma confer call et learn meet
catalyst theme may
agn focu result matter stock post proxi may
industri specialti pharma focus week biggest earn week
industri gener pharma sector takeaway post check channel check privat off-sit
investor call thought volatil may
industri gener pharma sun natco read-through color call us gener stock
link opioid/collus headlin may
price prior trade day market close estimate unless otherwis note
valu usd unless otherwis note
capit market appreci consider institut investor all-america research survey
publish note may order read
specialti pharma top-read note may
teva execut solid stock reaction remind cash flow de-lev drive share
strategi detail ep re-set execut valuat debat continu
zilretta ramp evidenc sizabl april help assuag concern may
industri specialti pharma short interest sever larg move period ahead focu
may
earli turnaround encourag thought forward post-manag call may
industri specialti pharma confer stock watch top theme
industri specialti pharma focus week gx price fix expert call mon
industri specialti pharma focus week ok/opioid trial cross-
industri gener pharma closer look earn set-up thought buy-sid
versu sell-sid expect focu may
pipelin updat move forward focu may
industri gener pharma lupin report read teva
fundament tone encourag lot pertin cross-read may
would continu buy strength post bullish dinner runway clear pt
overal solid quarter despit stock reaction guidanc re-affirmed expect may
clean quarter littl debat xyrem life-cycle need remain focu may
industri specialti pharma short interest -sector si higher continu sector pressur
focu teva may
industri specialti pharma top-read note april still top focu teva interest high
debat continu may
ebitda miss drive share lower concern around ramp center stage
closer look five question matter turnaround ebitda ramp may
industri specialti pharma focus week gener corpor off-sit
specialti pharma top-read note may
kmph partnership process final stage per updat may
still earli turnaround sign progress underway may
closer look recent weak lower ep focu high rx separ
agrx stori remain on-track resubmiss immin set-up key catalyst may
aqst bring slew updat liberv nda file remain on-track may
nda re-submiss time slip plan otherwis remain track may
littl new eve approv favor set-up gvoke pdufa may
earli launch feedback remain encourag long road ahead lower pt may
weak drive question frame opioid exposur may
outlook go rais question messag focu et call
agn agn earn call instil confid statu quo strateg messag
thought call may
mix re-affirmed guidanc expect focu revenu miss call
industri gener pharma expert confer call gener price fix alleg start
et may
agn agn aesthet cross-read analyst day takeaway may
industri gener cross-read teva result encourag
would call may
industri gener pharma cross-read dr reddi earn call teva
aqst may
 nv deal acquir xiidra remov less obviou restasi life-cycl opportun
impact outlook may
outlook better expect encourag add support
share may
specialti pharma top-read note may
report mix ebitda ramp reliant pipelin call et
industri revanc inc highlight global healthcar
industri gener pharma taro cross-read earn call consist color price
teva teva mix ebitda line re-affirmed outlook low expect
cc et may
result mix ahead analyst meet tomorrow break
number remain cautiou may
 analyst day set begin initi consolid ep guid expect
lot move part may
endo intern highlight global healthcar confer
need figur plan go strateg messag
market address four question follow confer present may
exparel gener line expect guidanc re-affirmed
support may
flexion therapeut highlight global healthcar confer
pharmaceut highlight global healthcar confer
akorn inc highlight global healthcar confer may
report solid chang outlook confer call may
expect strength competitor see clear path meaning upsid
may
industri healthcar confer takeaway therapeut team call start et
announc posit phase top-lin result blepharoptosi
confer call tomorrow et may
 symphoni data april show continu high teen growth host
manag today may
pacira bioscienc highlight global healthcar confer
 phase data kol feedback lend support
specialti pharma top-read note may
amneal pharmaceut inc highlight global healthcar
inc highlight global healthcar confer may
eagl pharmaceut highlight global healthcar confer
osmotica pharmaceut highlight global healthcar
kmph kempharm inc kmph highlight global healthcar confer
xeri pharmaceut highlight global healthcar confer
evofem bioscienc inc highlight global healthcar
agrx agil inc agrx highlight global healthcar
aqst aquest inc aqst highlight global healthcar
specialti pharma top-read note may
